APOBEC3-associated mutations in cancers more frequently present in APOBEC3A-preferred YTCA sequence contexts, compared with APOBEC3B-preferred RTCA sequence contexts (where Y indicates a pyrimidine base and R is a purine base, and C is the mutated base)23. This evidence concerns the gene APOBEC3B and cancer.